Chehalis, Washington

Overview

Capital Oncology in Chehalis, Washington serves as a critical healthcare facility for the surrounding region. Located in Washington, this hospital draws visitors and residents from a wide catchment area that spans multiple incorporated communities. Understanding the population base within a 30-minute drive helps illustrate the regional significance of this location and the communities it connects.

Population catchment

Within a 30-minute drive of Capital Oncology, approximately 74,121 people reside across 16 incorporated places. The largest nearby community, Tumwater, contributes 25,350 residents to this total, making up about 34% of the area's population. The next largest communities are Centralia (18,183) and Chehalis (7,439), which together contribute an additional 25,622 residents to the catchment. The population distribution across these communities provides insight into the density and structure of the region.

Regional dependence

Many of the communities near Capital Oncology are relatively small, with 12 out of 16 falling below 5,000 residents. These smaller towns depend on proximity to Tumwater and regional destinations like Capital Oncology for everyday needs ranging from retail to medical care. This interdependence between small communities and larger centers is a defining feature of the area's geography.

Geographic interpretation

The demographic profile of the Capital Oncology catchment area reveals a suburban landscape. The area features a suburban pattern where several communities of moderate size coexist with smaller towns, creating a varied demographic landscape. Population concentration around Tumwater points to a moderately concentrated regional structure where access to amenities tends to correlate with proximity to the largest communities. With a median population of 1,879 across the nearby communities, the typical incorporated place is substantially smaller than the area's largest city. This geographic context is essential for understanding the practical reach of Capital Oncology.